Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment

被引:3
|
作者
Girardin, Francois R. [1 ]
Cohen, Karen [2 ]
Schwenkglenks, Matthias [3 ,4 ]
Durand-Zaleski, Isabelle [5 ]
机构
[1] Univ Lausanne, Lausanne Univ Hosp, Fac Med, Dept Lab Med & Pathol,Div Clin Pharmacol, Lausanne, Switzerland
[2] Univ Cape Town, Dept Med, Div Clin Pharmacol, Cape Town, South Africa
[3] Univ Basel, Inst Pharmaceut Med ECPM, Basel, Switzerland
[4] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland
[5] Univ Paris Est Creteil, Hotel Dieu, AP HP, URCEco, Paris, France
关键词
pharmacoeconomics; health technology assessment (HTA); patient related outcome; disinvestment choices; cost-effectiveness; SURROGATE END-POINTS;
D O I
10.3389/fphar.2023.1210002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Research on Investment Risk Warning of Technology Innovation in High-tech Enterprises
    Ma, Zhongmin
    PROCEEDINGS OF THE 2017 INTERNATIONAL CONFERENCE ON HUMANITIES SCIENCE, MANAGEMENT AND EDUCATION TECHNOLOGY (HSMET 2017), 2017, 96 : 628 - 633
  • [32] Patient-reported Outcomes Data in Health Technology Assessment: Use in Germany and Beyond
    Wieseler, Beate
    Thomas, Stefanie
    QUALITY OF LIFE RESEARCH, 2024, 33 : S10 - S10
  • [33] RESOURCE USE EFFICIENCY AND RETURNS TO INVESTMENT IN RESEARCH OF PEARL MILLET IN RAJASTHAN
    Shaktawat, Seema
    Singh, I. P.
    Nagaraj, N.
    Sharma, Shirish
    INDIAN JOURNAL OF ECONOMICS AND DEVELOPMENT, 2012, 8 (04) : 1 - 11
  • [34] Research on Government Dynamic Strategies for Mining Technology Investment of Mineral Resource Enterprises
    Wang, Ning
    Tan, Deqing
    INTERNATIONAL GAME THEORY REVIEW, 2024,
  • [35] Board Interlocks with Information Technology Firms and Innovation Outcomes: A Resource Dependence Perspective
    Liu, Xiaowei
    Pinsonneault, Alain
    Qu, Wen Guang
    Dong, John Qi
    JOURNAL OF MANAGEMENT INFORMATION SYSTEMS, 2024, 41 (03) : 812 - 838
  • [36] WHAT DRIVES PRIVATE INVESTMENT IN HEALTH ECONOMICS AND OUTCOMES RESEARCH?
    Bajaj, P. S.
    Willke, R. J.
    Sullivan, S. D.
    Garrison, L. P.
    VALUE IN HEALTH, 2014, 17 (03) : A22 - A22
  • [37] APPLICATION OF HEALTH TECHNOLOGY ASSESSMENT AND PHARMACOECONOMICS IN THE DECISION-MAKING PROCESS IN SELECTED EU MEMBER STATES
    Marusakova, E.
    Bielik, J.
    VALUE IN HEALTH, 2013, 16 (07) : A679 - A679
  • [38] Innovation and technology for sustainable mining activity: A worldwide research assessment
    Aznar-Sanchez, Jose A.
    Velasco-Munoz, Juan F.
    Belmonte-Urena, Luis J.
    Manzano-Agugliaro, Francisco
    JOURNAL OF CLEANER PRODUCTION, 2019, 221 : 38 - 54
  • [39] Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group
    Leahy, Joy
    Hickey, Conor
    McConnell, David
    Cassidy, Owen
    Trela-Larsen, Lea
    Barry, Michael
    Tilson, Lesley
    McCullagh, Laura
    VALUE IN HEALTH, 2020, 23 (11) : 1423 - 1426
  • [40] MAKING WORDS COUNT: OPPORTUNITIES FOR INNOVATION IN HEALTH TECHNOLOGY ASSESSMENT
    Pritlove, C.
    Garces, K.
    Burns, B.
    VALUE IN HEALTH, 2019, 22 : S62 - S62